• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number ESP100-21
Device Problems Backflow (1064); Material Integrity Problem (2978); Material Split, Cut or Torn (4008)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717)
Event Date 06/02/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2011, a 21mm epic supra valve w/flexfit was selected for implant.On (b)(6) 2020, the patient presented to the hospital after she became aware of abnormal heart sounds.On (b)(6) 2020, the valve was explanted after severe aortic regurgitation and stenosis was confirmed on echocardiogram.The valve was replaced with a 21mm sjm regent heart valve w/flex cuff.Upon explant, a tear of the stent post was confirmed.The physician reported that the durability of the valve might have been affected by the patient's age at the time of implant.The patient was reported to be in stable condition.
 
Manufacturer Narrative
Correction: d3.Additional information: d10,g4,h2, h3, h6, h10.The tear, noted at explant following explant due to stenosis and regurgitation, was confirmed upon analysis.All cusps contained tears, with thinning of the tissue at their base.A micro calcification was noted in cusp 3.The annular suture line was disrupted.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Two videos of the explant procedure were received for analysis.During explant, tissue was removed from the inflow surface of the valve, which may have caused the reported damage at explant and appeared to align with the thin areas of cuspal tissue noted upon analysis.It is also unknown if this explant damage affected the severity of the tears.In the absence of any calcification or evidence of infection, the reported event is consistent with a non-calcific leaflet tear.A non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.Histological evaluation revealed mild loss of collagen at one of the tear sites, which could have contributed to the tear.Furthermore, if the tissue attached to the inflow surface of the valve prior to explant had the potential to narrow the flow of blood and induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC SUPRA VALVE W/FLEXFIT
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA)
caixa postal 106
engenho nogueira - belo horizonte - mg
belo horizonte 34000 -000
BR  34000-000
MDR Report Key10211592
MDR Text Key197203021
Report Number3001883144-2020-00055
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/03/2014
Device Model NumberESP100-21
Device Lot Number3400505
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/30/2020
Was the Report Sent to FDA? No
Date Manufacturer Received08/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other; Required Intervention;
Patient Age68 YR
Patient Weight56
-
-